Pharmacovigilance and adverse event monitoring are critical functions for healthcare organizations to ensure patient safety and comply with regulatory requirements. However, monitoring drug safety and identifying potential adverse events can be challenging, particularly given the volume and complexity of data involved. By leveraging AI, healthcare organizations can more quickly and accurately identify potential adverse events, enabling them to take action earlier to mitigate risk and ensure patient safety. AI has the potential to transform pharmacovigilance and adverse event monitoring by enabling more efficient and accurate identification of potential adverse events, improving patient safety and reducing the risk of regulatory penalties.